Abstract
Objective: To compare the diagnostic capabilities of various serum thyroglobulin levels (Tg) and Tl-201 scintigraphy with regard to thyroid follicular lesions.Methods: We examined 80 thyroid follicular lesions (benign: 55, malignant: 25) in patients with nodular goiter for whom a pathological diagnosis was made based on surgical findings. Tg was measured by an I-125 (radioimmunoassay) method. In Tl-201 scintigraphy, 74 MBq of Tl-201 chloride was intravenously injected and imaged after 10 minutes (early image) and after 120 minutes (delayed image), and the scintigrams were evaluated both visually and quantitatively, with special attention paid to the part of the nodule with the highest accumulation of Tl-201 chloride. The cutoff levels of Tg for categorizing the lesions as malignant were set at 40, 100, 300, 500, 1,000 and 2,500 μg/l. In Tl-201 scintigraphy, method 1 involved high uptake on both early and delayed images, method 2 involved high uptake on only the early image, and method 3 involved high uptake on only the early image or the same accumulation in comparison with the normal region on the early image, with no washout being quantitatively judged as indicative of malignancy. A summary index of overall test performance can be calculated as the area under the receiver operating characteristic (ROC) curve (Area (Az)). Likelihood ratios for several cutoff levels were also calculated.Results: In the diagnosis, Az of Tl-201 (0.95) was larger than that of Tg (0.65). The sensitivity and accuracy of Tg at each cutoff level (sensitivity: 4.0% to 76.0%, accuracy: 50.0% to 72.5%) were lower than with Tl-201 scintigraphy (methods 1–3, sensitivity: 76.0–100%, accuracy: 77.5–88.8%). The likelihood ratio for the positive results of method 1 for Tl-201 scintigraphy, were greatest in the present study (13.9), and the likelihood ratio for the negative results of method 3 for Tl-201 scintigraphy, (0) was smallest in the present study.Conclusion: Diagnosis based on Tl-201 washout patterns in which quantitative evaluation is combined with visual evaluation appears to be more useful for the differentiation of malignant thyroid follicular lesions than diagnosis by Tg.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy.Ann Intern Med 1968; 69: 537–540.
Ashcraft MW, Van Herle AJ. Management of thyroid nodules II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration.Head & Neck Surg 1981; 3: 297–322.
Van Herle AJ, Rich P, Ljung BME, Ashcraft MW, Solomon DH, Keeler EB. The thyroid nodule.Ann Intern Med 1982; 96: 221–232.
Nakahara H, Noguchi S, Murakami N, Hoshi H, Jinnouchi S, Nagamachi S, et al. 99m Technetium-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.J Nucl Med 1996; 37: 901–904.
Okamoto T, Kanbe M, Iihara M, Yamazaki K, Okamoto J, Yamashita T, et al. Measuring serum thyroglobulin in patients with follicular thyroid nodule: its diagnostic implications.Endocrine J 1997; 44: 187–193.
Okumura Y, Takeda Y, Sato S, Komatsu M, Nakagawa T, Akaki S, et al. Comparison of differential diagnostic capabilities of Tl-201 scintigraphy and fine-needle aspiration of thyroid nodules.J Nucl Med 1999; 40: 1971–1977.
Mazzaferri EL. Management of a solitary thyroid nodules.N Engl J Med 1993; 328: 553–559.
Ridgway EC. Clinician’s evaluation of a solitary thyroid nodule.J Clin Endocrinol Metab 1992; 74: 231–235.
Ridgway EC. Clinical evaluation of solitary thyroid nodules. In:Werner and Ingbar’s The Thyroid, Bravernman LE, Utiger RD (eds), Philadelphia, PA: Lippincott, 1991: 1197–1203.
Sarne DH, Refetoff S. Thyroid function tests. In:Endocrinology, De Groot LJ (ed), Philadelphia, PA: Saunders, 1995; 617–664.
Refetoff S, Lever EG. The value of serum thyroglobulin measurement in clinical practice.JAMA 1983; 250: 2352–2357.
Hisada K, Tonami N, Miyamae T, Hiraki Y, Yamazaki T, Maeda T, et al. Clinical evaluation of tumor imaging with Tl-201 chloride.Radiology 1978; 129: 497–500.
Freitas IE, Cross MD, Rioley S, Shapiro B. Radionuclide diagnosis and therapy of thyroid cancer: current status report.Seminars Nucl Med 1985; 15: 106–131.
Senga O, Miyakawa M, Shirota H, Makiuchi M, Yano K, Miyazawa M, et al. Comparison of Tl-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumor: concise communication.J Nucl Med 1982; 23: 225–228.
Koizumi M, Taguchi H, Goto M, Nomura T, Watari T. Thallium-201 scintigraphy in the evaluation of thyroid nodules: a retrospective study of 246 cases.Ann Nucl Med 1993; 7: 147–152.
Ochi H, Sawa H, Fukuda T, Inoue Y, Nakajima H, Masuda Y, et al. Thallium-201 chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: usefulness of the delayed scan.Cancer 1982; 50: 236–240.
Derebek E, Biberoglu S, Kut O, Yesil S, Saydam S, Yilmaz M, et al. Early and delayed thallium-201 scintigraphy in thyroid nodules: the relationship between early thallium-201 uptake and perfusion.Eur J Nucl Med 1996; 23: 504–510
Hardoff R, Baron E, Sheinfeld M. Early and late lesion-to-non-lesion ratio of thallium-201-chloride uptake in the evaluation of “cold” thyroid nodules.J Nucl Med 1991; 32: 1873–1876.
Hermans J, Schmitz A, Therasse G, Eeckhoudt L, Beauduin M. Thyroid scintigraphy with thallium 201: non-traumatic method for early detection of tumours and a better assessment of patients suitable for operation.Acta Oto-Rhino-Laryngologica Belgica 1987; 41: 649–655.
Henze E, Roth J, Boerer H, Adam WE. Diagnostic value of early and delayed Tl-201-thyroid scintigraphy in the evaluation of cold nodules for malignancy.Eur J Nucl Med 1986; 11: 413–416.
Bleichrodt RP, Vermey A, Piers DA, Langen ZJ. Early and delayed thallium 201 imaging: diagnosis of patients with cold thyroid nodules.Cancer 1987; 60: 2621–2623.
Metz CE, Herman BA, Shen J-H. Maximum-likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data.Statistics in Medicine 1998; 17: 1033–1053.
Greenberg RS, Daniels SR, Flanders WD, Eley JW, Boring JR III. Diagnostic testing. In:Medical Epidemiology, 3rd ed. New York; McGraw-Hill Medical Publishing Division, 2001; 77–89.
Kume N, Suga K, Nishigauchi K, Kawamura M, Matsunaga N. Relationship between thallium-201 uptake and tumour proliferative ability in thyroid nodules.Eur J Nucl Med 1996; 23: 376–382.
Czyz W, Joensuu H, Pylkkanen L, Klemi PJ. P53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.J Pathol 1994; 174: 267–274.
Uematsu H, Sadato N, Ohtsubo T, Tsuchida T, Nakamura S, Sugimoto K, et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.J Nucl Med 1998; 39: 453–459.
Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography.Surgery 1993; 114: 728–735.
Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A. High frequency of cancer in cold thyroid nodules occurring at young age.Acta Endocrinol 1989; 121: 197–202.
Werk EE Jr, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC. Cancer in thyroid nodules: a community hospital survey.Arch Intern Med 1984; 144: 474–476.
Ross DS. Evaluation of thyroid nodule.J Nucl Med 1991; 32: 2181–2192.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tamizu, A., Okumura, Y., Sato, S. et al. The usefulness of serum thyroglobulin levels and Tl-201 scintigraphy in differentiating between benign and malignant thyroid follicular lesions. Ann Nucl Med 16, 95–101 (2002). https://doi.org/10.1007/BF02993711
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02993711